arsenic trioxide has been researched along with dicumarol in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, YY; Hu, QS; Jing, YW; Li, H; Shi, GY; Tang, XM; Yi, J | 1 |
1 other study(ies) available for arsenic trioxide and dicumarol
Article | Year |
---|---|
Dicoumarol alters cellular redox state and inhibits nuclear factor kappa B to enhance arsenic trioxide-induced apoptosis.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Dicumarol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Emodin; Enzyme Inhibitors; HeLa Cells; Humans; NF-kappa B; Oxidation-Reduction; Oxides; Reactive Oxygen Species | 2004 |